PENTAX Medical Launches Innovative J10 Series Endoscopic Ultrasound Gastroscopes In the USA

September 15, 2020

PENTAX Medical has announced the launch of the new J10 Series Ultrasound Video Gastroscopes.

In assessing GI diseases, endoscopic ultrasound (EUS) is a minimally invasive and highly accurate procedure that uses high-frequency sound waves to produce detailed images of tissue and surrounding organs such as the pancreas and liver. While used primarily for diagnostic procedures such as EUS-guided Fine Needle Aspiration (EUS-FNA), EUS-guided Fine Needle Biopsy (EUS-FNB), and tumor staging, there has been a shift towards using EUS for interventional procedures and to treat pancreaticobiliary diseases as a less-invasive option than ERCP.

The new PENTAX Medical J10 Series Ultrasound Video Gastroscopes deliver on both clinical and market needs, offering ergonomic design, renowned image quality and enhanced maneuverability as an EUS solution.

With ultrasound gastroscopes, high functionality and performance are critical for success, given that indications are so varied. Designed for optimal procedural efficiency in EUS, the new J10 Series Ultrasound Video Gastroscopes provide a lightweight and ergonomic control body design to ensure stability and ease of intubation while reducing hand fatigue. With a proven PENTAX-Hitachi image quality to support visual certainty and diagnoses, the J10 Series produces greater detail, clearer delineation, and superior penetration. Additionally, maneuvering, device control, and instrument compatibility are augmented with shorter rigid distal section lengths, increased tip deflection, smaller bending radius and an enlarged working channel.

“With the immense success of the J10 Series endoscopes since their introduction in other global regions, we are now very pleased and excited for their introduction in the USA as well,” stated Gerald W. Bottero, Global President of PENTAX Medical. “With a focus on exceptional maneuverability and high-definition endoscopic imaging, the J10 Series provides an innovative solution for performing endoscopic evaluations, increasing diagnostic capabilities, and determining pathways for effective patient management.”

Specific enhancements with the new J10 Series Ultrasound Video Gastroscopes include increased linear scope scan angle of 150° for broader imaging, increased frequency (13MHz) for near-field exploration, widened depth of field range (3mm–100mm), increased angulations to optimize access in the GI tract, and sealed elevator wire channels to help reduce risk of cross-contamination. The EG38-J10UT also has an enlarged instrument channel width (4mm), expanding therapeutic capabilities to advance EUS-guided intervention while providing full control of the procedure.

The new J10 Series is really a step forward in the set-up and portfolio of endoscopic ultrasound,” said Dr. Paolo G. Arcidiacono, Ospedale San Raffaele, Milan, Italy. “It is a significant improvement on both the endoscopic and the endosonographic side. Particularly for therapeutic procedures, the improved endoscopic view has solved previous compromises.”

The J10 Series is commercially available now. An exclusive Virtual Launch Event is scheduled for October 14, 2020 at 6:00 PM EDT. Three renowned endoscopic ultrasound experts will present difficult EUS cases and discuss the potential benefits and differences of the new J10 Series lineup.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version